Platinum-resistant Primary Peritoneal Carcinoma
📧 Sign up to get email alerts when something new happens for Platinum-resistant Primary Peritoneal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating Bevacizumab in combination with Anetumab Ravtansine or Paclitaxel for refractory ovarian, fallopian tube, …